Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed

MLA

L. Zubiri, et al. Thymidylate Synthase Polymorphisms in Genomic DNA as Clinical Outcome Predictors in a European Population of Advanced Non-Small Cell Lung Cancer Patients Receiving Pemetrexed. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bcd411ed47e5ac54143ddfa3eebb2e88&authtype=sso&custid=ns315887.

APA

L. Zubiri, E. Arevalo, Josefa Salgado, Patricia Martin, Víctor Collado, Maria E. Rodriguez-Ruiz, Inés López, Ana Patiño-García, Ignacio Gil-Bazo, Marta Santisteban, Eduardo Castanon, & Christian Rolfo. (2014). Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.

Chicago

L. Zubiri, E. Arevalo, Josefa Salgado, Patricia Martin, Víctor Collado, Maria E. Rodriguez-Ruiz, Inés López, et al. 2014. “Thymidylate Synthase Polymorphisms in Genomic DNA as Clinical Outcome Predictors in a European Population of Advanced Non-Small Cell Lung Cancer Patients Receiving Pemetrexed,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bcd411ed47e5ac54143ddfa3eebb2e88&authtype=sso&custid=ns315887.